Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · Real-Time Price · USD
0.3400
+0.0059 (1.77%)
May 13, 2025, 4:00 PM - Market closed
Turnstone Biologics Employees
Turnstone Biologics had 14 employees as of December 31, 2024. The number of employees decreased by 66 or -82.50% compared to the previous year.
Employees
14
Change (1Y)
-66
Growth (1Y)
-82.50%
Revenue / Employee
n/a
Profits / Employee
-$4,501,000
Market Cap
7.87M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 14 | -66 | -82.50% |
Dec 31, 2023 | 80 | -28 | -25.93% |
Dec 31, 2022 | 108 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
TSBX News
- 5 days ago - Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent Corporate Highlights - GlobeNewsWire
- 6 weeks ago - Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 6 months ago - Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting - GlobeNewsWire
- 9 months ago - Turnstone Biologics Shifts Focus To 'High Unmet Medical Need' Cancers, Shares Initial Data From Colorectal Cancer Cell Therapy Study - Benzinga
- 9 months ago - Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 9 months ago - Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer - GlobeNewsWire
- 1 year ago - Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 1 year ago - Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference - GlobeNewsWire